Delivery Order SPE2DB22D2211-SPE2DB25FSEUB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,490.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication used for localized pain relief. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,029.81 and an ultimate completion date of August 18, 2025. The contract involves no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $41,111.42 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, a topical anesthetic medication. Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, a topical anesthetic medication commonly used for localized pain relief in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order has a ceiling value of $64,690.07 and was issued on September 4, 2025, with a completion date of September 5, 2025. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,607.99 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30S, a topical anesthetic medication commonly used for localized pain relief. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain relief in military and federal healthcare settings. This firm fixed-price delivery order, valued at $1,478.64, was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract is unclassified as a set-aside and represents a competitive award to the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lidocaine 5% Patch 30S, a topical pain management pharmaceutical product. This firm fixed-price delivery order, valued at $2,671.51, is scheduled for completion by August 11, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lidocaine 5% Patch 30S with a ceiling value of $10,877.33. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 11, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a $7,010.69 delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30 count) with an ultimate completion date of September 4, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $20,666.23 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic pharmaceutical product. The contract, executed on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed-price pricing under a non-set-aside, competitively awarded arrangement. Performance of this delivery order is based in Conshohocken, Pennsylvania, the headquarters location of...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEUBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,986.40 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical anesthetic medication commonly used for localized pain relief. The contract, executed on September 11, 2025, with an ultimate completion date of September 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements, with this award reflecting its role as a critical vendor for military and veteran healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/11/25 |